Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-18-038134

Options or other derivatives

  • Director acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DESOUZA ERROL B · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-06-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +5,000 $24.94 2028-06-13 5,000 5,000 D
Loading xslF345X03/doc4.xml…